Callitas Health (MPHMF) & Occidental Petroleum (OXY) Critical Contrast
Callitas Health (NYSE: OXY) and Occidental Petroleum (NYSE:OXY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.
This is a breakdown of recent ratings and target prices for Callitas Health and Occidental Petroleum, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Risk and Volatility
Callitas Health has a beta of -0.95, suggesting that its stock price is 195% less volatile than the S&P 500. Comparatively, Occidental Petroleum has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500.
This table compares Callitas Health and Occidental Petroleum’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings and Valuation
This table compares Callitas Health and Occidental Petroleum’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Occidental Petroleum||$13.27 billion||4.48||$1.31 billion||$0.89||87.42|
Occidental Petroleum has higher revenue and earnings than Callitas Health.
Insider & Institutional Ownership
80.4% of Occidental Petroleum shares are owned by institutional investors. 0.3% of Occidental Petroleum shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Occidental Petroleum pays an annual dividend of $3.12 per share and has a dividend yield of 4.0%. Callitas Health does not pay a dividend. Occidental Petroleum pays out 350.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Occidental Petroleum has raised its dividend for 15 consecutive years.
Occidental Petroleum beats Callitas Health on 11 of the 12 factors compared between the two stocks.
About Callitas Health
Callitas Health Inc., a biomedical technology company, develops and commercializes technologies for obesity, weight management, and female health and wellness in Canada. The company offers obesity drug C-103, a reformulation of Orlistat; ToConceive, a fertility enhancing moisturizer; and Extrinsa for female sexual dysfunction solutions. The company was formerly known as M Pharmaceutical Inc. and changed its name to Callitas Health Inc. in September 2017. Callitas Health Inc. was founded in 2003 and is headquartered in Vancouver, Canada.
About Occidental Petroleum
Occidental Petroleum Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of oil and gas properties in the United States and internationally. The company operates through three segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops, and produces oil and condensate, natural gas liquids (NGLs), and natural gas. The Chemical segment manufactures and markets basic chemicals, including chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates, and calcium chloride; vinyls comprising vinyl chloride monomer, polyvinyl chloride, and ethylene. The Midstream and Marketing segment gathers, processes, transports, stores, purchases, and markets oil, condensate, NGLs, natural gas, carbon dioxide, and power. This segment also trades around its assets consisting of transportation and storage capacity; operates a crude oil export terminal; and invests in entities. Occidental Petroleum Corporation was founded in 1920 and is headquartered in Houston, Texas.
Receive News & Ratings for Callitas Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callitas Health and related companies with MarketBeat.com's FREE daily email newsletter.